Jacob is a senior reporter at BioPharma Dive, where he covers the intersection of science and business. Jacob writes about breakthrough developments in neuroscience, cutting-edge treatments for rare diseases, as well as biotech funding and venture capital. He is also behind the award-winning column Pharmacquired, which takes a closer look at how and why biopharma deals get done.
4:00 PM - 5:00 PM (EST)
Tuesday, February 16